Clinical trial
Study to Collect Data on Fabry Disease Patients With Enhanceable…
NCT00106912 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00106912 |
|---|---|
| Title | Study to Collect Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity |
| Official title | A Study to Collect Normative Data on Fabry Disease Patients With Enhanceable Alpha-Galactosidase A Activity |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Fabry Disease |
| Enrollment | 35 |
| Start date | Mar 28, 2005 |
| Completion | Mar 27, 2008 |
| First posted | Apr 1, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: